accord
data
releas
world
health
organ
infecti
agent
caus
lower
respiratori
infect
diarrheal
diseas
tuberculosi
rank
top
ten
caus
death
worldwid
result
million
death
clear
need
improv
understand
diseas
pathogen
agent
order
develop
effect
drug
vaccin
end
need
suitabl
anim
model
accur
mimic
pathogenesi
infect
infect
usual
induc
complex
process
host
immun
respons
vitro
experi
unabl
simul
vivo
model
accur
assess
complex
host
respons
allow
efficaci
advers
effect
drug
vaccin
evalu
syrian
hamster
mesocricetu
auratu
use
anim
model
studi
humanassoci
diseas
year
number
studi
document
syrian
hamster
repres
better
model
analysi
viral
infect
compar
murin
model
similar
human
regard
diseas
symptom
pathognesi
immun
respons
greater
demonstr
us
other
human
cytokin
includ
granulocytemacrophag
colonystimul
factor
gmcsf
fulli
function
hamster
model
mous
model
togeth
advantag
fast
reproduct
rate
eas
handl
syrian
hamster
superior
choic
compar
small
anim
although
syrian
hamster
histor
use
diseas
research
valu
anim
model
studi
infecti
diseas
recent
realiz
advanc
gene
edit
technolog
popular
increas
significantli
figur
use
genet
engin
syrian
hamster
gesh
model
critic
understand
diseas
progress
develop
prophylact
therapeut
treatment
regimen
first
gene
knockout
ko
syrian
hamster
develop
use
system
target
hamster
germlin
crucial
element
type
interferon
ifn
signal
transduct
pathway
hamster
model
emerg
small
anim
model
permiss
adenoviru
adv
infect
thu
ko
model
critic
character
adenoviru
pathogenesi
intens
studi
viru
syrian
hamster
west
nile
viru
wnv
wnv
member
genu
flaviviru
famili
flavivirida
emerg
zoonot
arboviru
wide
distribut
throughout
world
wnv
usual
transmit
via
bite
infect
arthropod
mosquito
human
major
wnv
infect
asymptomat
infect
individu
develop
symptomat
west
nile
fever
wnf
howev
wnv
import
emerg
neurotrop
viru
caus
sever
enceph
human
pose
signific
threat
global
health
syrian
hamster
readili
infect
mosquito
bite
ingest
oral
needl
inocul
infect
hamster
develop
viremia
ill
symptom
similar
experienc
human
infect
use
hamster
model
xiao
et
al
observ
histolog
abnorm
appear
viral
antigen
brain
first
follow
spinal
cord
infect
eventu
lead
acut
central
nervou
system
cn
injuri
infect
hamster
develop
neurolog
diseas
associ
suppress
diaphragmat
electromyograph
emg
infect
medulla
oblongata
samuel
et
al
also
found
inocul
syrian
hamster
wnv
result
paralysi
hind
limb
ipsilater
contralater
inject
site
mateo
et
al
gener
model
immunosuppress
syrian
hamster
use
cyclophosphamid
infect
hamster
display
similar
clinic
sign
observ
immunosuppress
cancer
patient
infect
wnv
observ
pathogenesi
diseas
wnvinfect
immunocompromis
hamster
anim
shown
develop
chronic
viremia
sustain
renal
infect
month
syrian
hamster
display
adapt
immun
respons
also
mount
innat
immun
respons
wnv
infect
sinc
syrian
hamster
shown
suitabl
model
wnv
infect
also
use
test
efficaci
antiwnvneutr
human
monoclon
antibodi
antibodi
immunoprophylaxi
induc
deliveri
recombin
antigen
also
protect
syrian
hamster
wnv
infect
use
syrian
hamster
model
widman
et
al
success
demonstr
replivax
wn
singl
cycl
flaviviru
vaccin
platform
abl
induc
durabl
protect
immun
wnv
challeng
studi
demonstr
syrian
hamster
ideal
model
studi
pathogenesi
wnv
infect
assess
new
approach
wnv
treatment
prevent
yfv
arthropodborn
viru
genu
flaviviru
famili
flavivirida
high
morbid
mortal
rate
region
subsaharan
africa
south
america
one
first
virus
human
identifi
isol
propag
vitro
studi
genom
sequenc
studi
infect
mechan
yfv
histor
hinder
lack
appropri
small
anim
model
nonhuman
primat
nhp
model
typic
use
recent
sever
research
group
gener
anim
model
use
syrian
hamster
success
infect
yfv
mcarthur
et
al
report
adapt
viral
strain
asibihamst
allow
reproduct
yellow
fever
diseas
hamster
featur
similar
human
diseas
studi
also
shown
infect
syrian
hamster
result
immun
respons
correspond
observ
infect
human
mark
increas
spleen
kidney
heart
reduc
level
seen
liver
addit
studi
found
increas
level
reduc
level
liver
spleen
heart
earli
midstag
infect
syrian
hamster
use
studi
pathogenesi
yfv
infect
valid
antivir
drug
antivir
therapi
recent
find
shown
treatment
antivir
compound
cytidin
ifn
pre
postyfv
exposur
significantli
improv
syrian
hamster
surviv
studi
juland
et
al
immun
adv
vector
express
ifn
alpha
effect
reduc
viral
titer
hamster
liver
serum
postyfv
infect
immunoprophylaxi
vaccin
contain
inactiv
yellow
fever
antigen
alum
adjuv
elicit
high
titer
neutral
antibodi
vivo
protect
syrian
hamster
yfv
infect
interestingli
xiao
et
al
tesh
et
al
demonstr
prior
exposur
syrian
hamster
heterolog
flavivirus
reduc
risk
yfv
infect
nipah
paramyxoviru
genu
henipaviru
famili
paramyxovirida
high
fatal
rate
infect
human
usual
caus
sever
encephalit
respiratori
diseas
inocul
nipah
viru
niv
syrian
hamster
also
develop
characterisit
neurolog
diseas
similar
symptom
human
infect
patholog
lesion
sever
extens
hamster
brain
viral
antigen
rna
detect
neuron
lung
kidney
spleen
syrian
hamster
major
niv
infect
studi
treat
intraperiton
ip
inject
intranas
deliveri
model
reveal
differ
inocul
method
caus
divers
patholog
respons
wong
work
ip
inject
niv
syrian
hamster
caus
primarili
neurolog
diseas
deliveri
develop
neurolog
symptom
well
labor
breath
due
lung
infect
final
stage
diseas
diseas
progress
usual
much
rapid
time
death
postinfect
shorter
follow
intraperiton
rather
intranas
inocul
sinc
syrian
hamster
shown
suitabl
studi
niv
infect
use
studi
viral
transmiss
demonstr
nipah
viru
transmit
effici
via
direct
contact
ineffici
via
fomit
via
aerosol
regard
use
model
develop
diseas
treatment
prophylaxi
recent
studi
shown
pretreat
poli
poli
significantli
decreas
mortal
caus
niv
infect
syrian
hamster
addit
model
use
platform
evalu
vaccin
niv
walpita
et
al
discov
purifi
nivlik
particl
vlp
protect
syrian
hamster
use
either
multipledos
singledos
vaccin
regimen
follow
niv
challeng
ebola
viru
ebov
one
five
known
virus
within
genu
ebolaviru
famili
filovirida
classifi
biosafeti
level
pathogen
syrian
hamster
effect
infect
mous
adapt
ebov
addit
display
major
hallmark
infect
pathogenesi
seen
human
nonhuman
primat
nhp
syrian
hamster
could
inocul
via
intraperiton
inject
mous
adapt
zair
ebola
viru
mazebov
patholog
caus
infect
similar
human
includ
signific
spleen
liver
damag
cytokin
dysregul
sever
coagulopathi
lymphocyt
apoptosi
infect
organ
necrosi
apoptosi
immun
respons
infect
syrian
hamster
includ
activ
cell
antibodi
product
recent
studi
result
ebola
viru
infect
hamster
demonstr
cell
requir
natur
immun
antibodi
respons
requir
immun
viru
model
syrian
hamster
use
evalu
bival
vaccin
compris
recombin
vesicular
stomat
viru
vsv
express
two
differ
immunogen
deriv
zebov
envelop
glycoprotein
and
viru
andv
result
show
singl
immun
vaccin
provid
hamster
complet
steril
protect
lethal
challeng
mazebov
andv
marburg
viru
marv
also
neg
sens
rna
viru
belong
famili
filovirida
caus
hemorrhag
fever
research
shown
syrian
hamster
use
studi
marv
infect
syrian
hamster
model
establish
studi
marv
infect
use
angola
variant
hamarv
studi
hamster
inocul
hamarv
develop
hemorrhag
manifest
coagul
abnorm
dysregul
proinflammatori
chemokin
increment
type
interferon
respons
addit
atkin
et
al
recent
develop
small
anim
model
wildtyp
marv
infect
use
ko
syrian
hamster
viral
replic
rapidli
progress
multiorgan
infect
extens
viremia
demonstr
key
host
factor
affect
wildtyp
marv
infect
rvfv
member
bunyavirida
famili
genu
phleboviru
rvfv
usual
transmit
via
bite
infect
mosquito
lead
mild
febril
ill
retin
fulmin
hepat
enceph
viral
hemorrhag
fever
infect
rvfv
syrian
hamster
welldescrib
studi
result
assess
suscept
syrian
hamster
rvfv
infect
shown
viral
infect
result
viremia
elev
viral
load
liver
brain
spleen
tissu
observ
sever
hepatocellular
necrosi
earli
stage
infect
intens
immunoreact
affect
hepatocyt
furthermor
use
syrian
hamster
scharton
et
al
prove
prophylact
favipiravir
effect
protect
infect
individu
rvfv
infect
reduc
delayedonset
neurolog
diseas
observ
ribavirin
treatment
anoth
studi
gowen
et
al
use
hamster
demonstr
protect
infect
singledos
intranas
treatment
vector
addtion
result
present
westov
et
al
demonstr
adenosin
analog
galidesivir
effect
reduc
rvfv
titer
infect
syrian
hamster
larg
number
studi
also
demonstr
syrian
hamster
permiss
small
anim
model
virus
exampl
syrian
hamster
model
success
use
test
efficaci
antif
mab
reduc
hendra
viru
infect
ko
syrian
hamster
shown
success
infect
zika
viru
zikv
infect
hamster
display
similar
symptom
human
also
immunosuppress
syrian
hamster
gener
schaecher
et
al
strengthen
valuabl
applic
studi
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
syrian
hamster
success
character
infect
human
influenza
includ
recent
virus
moreov
permiss
immunocompet
anim
model
studi
oncolyt
adenoviru
use
expand
studi
cancer
virotherapi
pathogen
leptospira
interrogan
spirochet
bacteria
respons
leptospirosi
widespread
emerg
neglect
zoonot
syrian
hamster
prefer
model
studi
infect
serovar
leptospira
interrogan
bacteria
travel
rapidli
bloodstream
via
lymphat
invad
tissu
infect
organ
prior
death
hamster
similar
human
presenc
leptospira
interrogan
detect
liver
kidney
destruct
hepatocyt
junction
lead
jaundic
thrombot
glomerulopathi
interstiti
nephriti
infect
anim
develop
enhanc
express
proinflammatori
cytokin
peripher
blood
cell
dramat
imbal
cytokin
product
upon
leptospira
infect
might
play
import
role
develop
sever
leptospirosi
sinc
syrian
hamster
shown
suitabl
model
use
test
efficaci
vaccin
diseas
palaniappan
et
al
demonstr
immun
syrian
hamster
recombin
liga
rliga
prevent
fatal
decreas
histopatholog
lesion
kidney
inhibit
growth
organ
anoth
studi
vaccin
use
conserv
region
leptospir
immunoglobulinlik
b
protein
ligb
aluminum
hydroxid
ah
significantli
increas
igg
igm
level
hamster
protect
anim
mortal
challeng
clostridium
difficil
diseas
caus
clostridium
difficil
infect
cdi
one
common
infecti
diseas
worldwid
increas
threat
morbid
mortal
caus
infect
mostli
due
emerg
hypervirul
strain
increas
use
misus
antibiot
use
mous
anim
model
unabl
provid
cdi
drug
discoveri
necessari
find
new
anim
model
sever
group
gener
syrian
hamster
model
cdi
develop
mani
clinic
symptom
observ
infect
human
studi
syrian
hamster
condit
singl
subcutan
inject
clindamycin
induc
clostridium
difficil
coliti
model
use
infect
model
efficaci
antibiot
clostridium
difficil
assess
oral
mixtur
kefirisol
bacteria
yeast
prevent
diarrhea
enterocol
trigger
clostridium
difficil
test
viscer
leishmaniasi
vl
also
known
kalaazar
sever
form
leishmaniasi
caus
leishmania
donovani
leishmania
infantum
leishmania
chagasi
america
syrian
hamster
highli
suscept
infect
viscer
leishmania
speci
consid
best
experiment
model
studi
vl
reproduc
clinicopatholog
featur
human
diseas
quit
distinct
note
murin
model
infect
major
studi
anim
infect
intracardi
rout
infect
anim
demonstr
upregul
express
cytokin
mrna
spleen
limit
induct
mrna
murin
model
leishmania
control
nitric
oxid
gener
howev
hamster
human
role
macrophag
function
induc
synthetas
ino
mrna
detect
liver
spleen
hamster
may
explain
uncontrol
parasit
replic
occur
hamster
human
despit
induct
strong
cytokin
respons
syrian
hamster
model
use
studi
pathogenesi
leishmania
donovani
infect
also
test
vaccin
recent
studi
shown
kushawaha
et
al
use
syrian
hamster
model
show
recombin
leishmania
donovani
protein
disulfid
isomeras
rldpdi
gener
robust
cellular
immun
respons
increas
ino
transcript
level
anoth
studi
samant
et
al
vaccin
dnaencod
ntermin
domain
ppg
gene
golden
hamster
yield
protect
leishmania
donovani
challeng
gener
type
immun
respons
besid
leishmania
donovani
leishmania
infantum
also
studi
use
syrian
hamster
model
moreira
et
al
gener
model
use
syrian
hamster
featur
similar
human
clinic
pictur
leishmania
infantum
infect
anim
develop
hepatosplenomegali
sever
weight
loss
anemia
leucopenia
studi
found
increas
level
igg
hamster
infect
leishmania
infantum
similar
human
syrian
hamster
develop
progress
fatal
diseas
major
site
parasit
replic
liver
spleen
bone
marrow
eventu
caus
death
host
infect
hamster
show
strong
humor
respons
leishmania
antigen
high
antibodi
level
studi
test
immun
dna
plasmid
code
salivari
protein
lu
longipalpi
protein
protect
hamster
fatal
outcom
vl
entamoeba
histolytica
popular
protozoan
parasit
caus
amebiasi
human
major
sourc
morbid
mortal
develop
countri
parasit
entamoeba
histolytica
produc
ameb
coliti
ameb
liver
abscess
ala
syrian
hamster
success
infect
entamoeba
histolytica
similar
symptom
human
infect
main
extraintestin
complic
ala
also
found
hamster
hamster
liver
recruit
neutrophil
initi
host
respons
entamoeba
histolytica
infect
studi
indic
leukocyt
induc
entamoeba
histolytica
trophozoit
undergo
cell
death
although
antiparasit
drug
metronidazol
exist
side
effect
toxic
exist
patient
thu
model
use
develop
altern
therapeut
agent
one
research
group
show
bovin
lactoferrin
protect
hepat
amoebiasi
syrian
hamster
model
hamster
also
use
show
intraperiton
inject
entamoeba
histolytica
surfac
metalloproteas
antigen
vaccin
protect
ameb
liver
abscess
studi
immun
stimul
robust
igg
antibodi
respons
igg
bound
surfac
entamoeba
histolytica
trophozoit
acceler
ameb
lysi
via
activ
classic
complement
cascad
anim
model
use
entamoeba
histolytica
infect
use
show
baculoviru
drive
express
gallectin
fragment
administeredvia
intramuscular
inject
increas
ifn
level
liver
protect
ala
schistosoma
haematobium
urinari
blood
fluke
etiolog
agent
urogenit
schistosomiasi
sourc
morbid
mortal
million
peopl
worldwid
although
improv
mous
model
haematobium
urinari
tract
infect
recapitul
sever
aspect
human
urogenit
schistosomiasi
syrian
hamster
still
show
advantag
compar
mous
syrian
hamster
transderm
infect
schistosoma
haematobium
cercaria
model
schistosoma
haematobium
cercaria
granulomatouslik
immun
reaction
hepat
fibrosi
infect
use
syrian
hamster
gener
botelho
et
al
botro
et
al
use
syrian
hamster
model
analyz
test
praziquantel
pzq
treatment
anim
model
reveal
predomin
cell
acut
phase
granuloma
format
liver
day
postinfect
pi
confluent
granulomata
multipl
egg
center
observ
liver
urinari
bladder
preponder
posit
cell
liver
day
pi
model
high
dose
pzq
clearli
cur
day
pi
mani
studi
detail
pathogenesi
bacteria
parasit
infect
use
syrian
hamster
anim
model
discuss
detail
syrian
hamster
model
studi
borrelia
burgdorferi
infect
establish
johnson
et
al
borrelia
burgodrferi
infect
hamster
util
studi
articular
manifest
lyme
borreliosi
similar
human
syrian
hamster
success
infect
leishmania
panamensi
infect
anim
upregul
express
type
ii
cytokin
downregul
upregul
type
ii
chemokin
receptor
lymph
node
grogl
et
al
gener
model
use
syrian
hamster
drug
discoveri
leishmania
panamesi
infect
leishmania
braziliensi
infect
ribeiroromao
et
al
observ
larg
ulcer
lesion
elev
level
tumor
necrosi
factor
tnf
infect
endpoint
suggest
cytokin
contribut
tissu
injuri
treatment
leishmania
amazonensi
infect
intralesion
administr
dimethyl
carbaporphyrin
ketal
ckome
reduc
parasit
load
without
notic
toxic
effect
liver
syrian
hamster
model
studi
plasmodium
berghei
infect
demonstr
induct
sever
malaria
syrian
hamster
window
chamber
model
use
investig
microcirculatori
chang
tissu
oxygen
reader
refer
relev
public
inform
regard
use
syrian
hamster
model
investig
infect
review
describ
use
syrian
hamster
model
extraordinarili
effect
relev
platform
evalu
molecular
mechan
immun
respons
infecti
diseas
studi
focu
sever
infecti
pathogen
includ
viral
parasit
bacteri
origin
result
indic
syrian
hamster
immun
respons
physiolog
similar
human
immun
respons
compar
anim
thu
offer
uniqu
advantag
studi
diseas
pathogenesi
novel
drug
treatment
discoveri
futur
studi
consid
determin
addit
similar
syrian
hamster
human
immun
respons
activ
pathogen
manipul
host
metabol
increas
research
effort
ultim
allow
develop
new
technolog
tool
studi
syrian
hamster
accur
sequenc
technolog
along
specif
antibodi
hamster
protein
current
limit
comparison
similar
tool
studi
murin
respons
infect
believ
recent
advanc
syrian
hamster
model
contribut
enorm
understand
infecti
diseas
diseas
manag
demonstr
strong
potenti
futur
research
develop
antivir
drug
discoveri
howev
discuss
lack
research
tool
repres
major
barrier
effect
use
syrian
hamster
model
immunolog
reagent
exam
host
immun
respons
particular
gene
express
transgen
diseas
model
requir
complet
evalu
valu
model
overcom
research
group
develop
identifi
consider
number
antibodi
syrian
hamster
tabl
hamster
specif
quantit
realtim
pcr
rtqpcr
transcriptom
analysi
microarray
also
develop
strikingli
technolog
rapidli
sped
creation
transgen
syrian
hamster
diseas
model
tool
overcom
limit
research
use
syrian
hamster
open
power
platform
recapitul
human
diseas
pathogensi
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
